Off-Label Direct Oral Anticoagulant Dosing: Caution Advised
Circulation: Cardiovascular Quality and Outcomes, <a href=”https://www.ahajournals.org/toc/circoutcomes/14/12″>Volume 14, Issue 12</a>, December 1, 2021. Source link
Read moreCirculation: Cardiovascular Quality and Outcomes, <a href=”https://www.ahajournals.org/toc/circoutcomes/14/12″>Volume 14, Issue 12</a>, December 1, 2021. Source link
Read moreBackground: Tafamidis is approved in many countries for the treatment of transthyretin amyloid cardiomyopathy. This study reports data on the
Read moreNancy K. Sweitzer Correspondence to: Nancy K. Sweitzer, MD, PhD, Cardiovascular Medicine, Sarver Heart Center, University of Arizona, 1501 N
Read moreCirculation: Heart Failure, Ahead of Print. Source link
Read moreCirculation: Heart Failure, Ahead of Print. Source link
Read moreBackground: Right ventricular dysfunction (RVD) is the leading cause of death in pulmonary arterial hypertension (PAH), but no RV-specific therapy
Read moreTelemedicine and e-Health, Volume 27, Issue 12, Page 1323-1324, December 2021. Source link
Read moreBackground The COVID-19 pandemic has caused a great deal of damage around the world and has affected the way society
Read moreIntroduction The utilization of telehealth has rapidly grown in recent years given its potential ability to improve access to specialized
Read moreCirculation: Heart Failure, Ahead of Print. Background:Heart failure has a disproportionate burden on patients who are Black, Indigenous, and people
Read more